Pacific Biosciences of California PACB Unrealized Gains on Investments
Unrealized Gains on Investments at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's unrealized gains on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacific Biosciences of California's unrealized gains on investments?
- Pacific Biosciences of California (PACB) reported unrealized gains on investments of $116K in Q1 2026.
- How has Pacific Biosciences of California's unrealized gains on investments changed year-over-year?
- Pacific Biosciences of California's unrealized gains on investments decreased by 74.4% year-over-year, from $453K to $116K.
- What is the long-term trend for Pacific Biosciences of California's unrealized gains on investments?
- Over 3 years (2022 to 2025), Pacific Biosciences of California's unrealized gains on investments has grown at a 205.9% compound annual growth rate (CAGR), from $16K to $458K.